Gene expression profiling of breast cancer
- PMID: 16518056
- DOI: 10.2325/jbcs.13.2
Gene expression profiling of breast cancer
Abstract
Numerous genes are controlled by complex regulatory networks and involved in the development and progression of breast cancer, and these genes are the key factors determining each characteristic of the tumor. Gene expression profiling, a large scale analysis of gene expression, has created new possibilities for the molecular characterization of cancer. Systematic analysis of expression patterns of thousands of genes in tumor cells using DNA microarrays and correlation of these patterns to specific features of phenotypic variation may provide the basis for an improved taxonomy of cancer. These profiles have the potential to explain the genetic heterogeneity of breast cancer and allow treatment strategies to be planned in accordance with their probability of success in individual patients.
Similar articles
-
[Gene expression profiling for prediction of response to chemotherapy].Gan To Kagaku Ryoho. 2006 Jan;33(1):1-5. doi: 10.2217/14750708.3.1.1. Gan To Kagaku Ryoho. 2006. PMID: 16410689 Review. Japanese.
-
Breast cancer gene microarrays pass muster.J Natl Cancer Inst. 2006 Oct 18;98(20):1438-40. doi: 10.1093/jnci/djj445. J Natl Cancer Inst. 2006. PMID: 17047189 No abstract available.
-
An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.Breast Cancer Res. 2009;11(4):R55. doi: 10.1186/bcr2344. Epub 2009 Jul 28. Breast Cancer Res. 2009. PMID: 19638211 Free PMC article.
-
[DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].Pathol Biol (Paris). 2006 Feb;54(1):49-54. doi: 10.1016/j.patbio.2005.02.003. Pathol Biol (Paris). 2006. PMID: 16376179 French.
-
Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?Int J Surg Pathol. 2009 Aug;17(4):285-302. doi: 10.1177/1066896908328577. Epub 2008 Dec 22. Int J Surg Pathol. 2009. PMID: 19103611 Review.
Cited by
-
Identifying causal genes and dysregulated pathways in complex diseases.PLoS Comput Biol. 2011 Mar;7(3):e1001095. doi: 10.1371/journal.pcbi.1001095. Epub 2011 Mar 3. PLoS Comput Biol. 2011. PMID: 21390271 Free PMC article.
-
Killer cell immunoglobulin-like receptor genes in patients with breast cancer.Med Oncol. 2012 Jun;29(2):511-5. doi: 10.1007/s12032-011-9932-x. Epub 2011 Apr 9. Med Oncol. 2012. PMID: 21479698 Clinical Trial.
-
HLA class-II allele frequencies in Turkish breast cancer patients.Med Oncol. 2012 Jun;29(2):466-71. doi: 10.1007/s12032-011-9873-4. Epub 2011 Mar 4. Med Oncol. 2012. PMID: 21373933
-
Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.Cancer Sci. 2011 Jan;102(1):130-6. doi: 10.1111/j.1349-7006.2010.01740.x. Epub 2010 Sep 30. Cancer Sci. 2011. PMID: 20880335 Free PMC article. Clinical Trial.
-
The role of talin2 in breast cancer tumorigenesis and metastasis.Oncotarget. 2017 Nov 6;8(63):106876-106887. doi: 10.18632/oncotarget.22449. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29290996 Free PMC article.